George Lambrinidis

Dr. George Lambrinidis

National and Kapodistrian University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in ACS Central Science
Verified
Journal Article
Open access
CMChunlong Ma
Chunlong Ma
MSMichael Dominic Sacco
Michael Dominic Sacco
ZXZilei Xia
Zilei Xia
GLGeorge Lambrinidis
George Lambrinidis
JTJulia Alma Townsend
Julia Alma Townsend
JWJun Wang
Jun Wang
The papain-like protease (PLpro) of SARS-CoV-2 is a validated antiviral drug target. Through a fluorescence resonance energy transfer-based high-throughput screening and subsequent lead optimization, we identified several PLpro inhibitors including Jun9-72-2 and Jun9-75-4 with improved enzymatic inhibition and antiviral activity compared to GRL0617, which was reported as a SARS-CoV PLpro inhibitor. Significantly, we developed a cell-based FlipGFP assay that can be applied to predict the cellular antiviral activity of PLpro inhibitors in the BSL-2 setting. X-ray crystal structure of PLpro in complex with GRL0617 showed that binding of GRL0617 to SARS-CoV-2 induced a conformational change in the BL2 loop to a more closed conformation. Molecular dynamics simulations showed that Jun9-72-2 and Jun9-75-4 engaged in more extensive interactions than GRL0617. Overall, the PLpro inhibitors identified in this study represent promising candidates for further development as SARS-CoV-2 antivirals, and the FlipGFP-PLpro assay is a suitable surrogate for screening PLpro inhibitors in the BSL-2 setting.

1 June 2015 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
GLGeorge Lambrinidis
George Lambrinidis
TVTheodosia Vallianatou
Theodosia Vallianatou
ATAnna Tsaantili
Anna Tsaantili

18 April 2016 in Nature Communications
Verified
Journal Article
Open access
YAYilmaz Alguel
Yilmaz Alguel
Sotiris AmillisSotiris Amillis
Sotiris Amillis
JLJames Leung
James Leung
GLGeorge Lambrinidis
George Lambrinidis
SCStefano Capaldi
Stefano Capaldi
BBBernadette Byrne
Bernadette Byrne
The uric acid/xanthine H+ symporter, UapA, is a high-affinity purine transporter from the filamentous fungus Aspergillus nidulans. Here we present the crystal structure of a genetically stabilized version of UapA (UapA-G411VΔ1–11) in complex with xanthine. UapA is formed from two domains, a core domain and a gate domain, similar to the previously solved uracil transporter UraA, which belongs to the same family. The structure shows UapA in an inward-facing conformation with xanthine bound to residues in the core domain. Unlike UraA, which was observed to be a monomer, UapA forms a dimer in the crystals with dimer interactions formed exclusively through the gate domain. Analysis of dominant negative mutants is consistent with dimerization playing a key role in transport. We postulate that UapA uses an elevator transport mechanism likely to be shared with other structurally homologous transporters including anion exchangers and prestin.

23 March 2017 in Molecules
Verified
Journal Article
Open access
PDF file
ECEliza Chaita
Eliza Chaita
GLGeorge Lambrinidis
George Lambrinidis
MCMaria-Christina Cheimonidi
Maria-Christina Cheimonidi
AAAdamantia Agalou
Adamantia Agalou
Dimitris BeisDimitris Beis
Dimitris Beis
NANektarios Aligiannis
Nektarios Aligiannis
In therapeutic interventions associated with melanin hyperpigmentation, tyrosinase is regarded as a target enzyme as it catalyzes the rate-limiting steps in mammalian melanogenesis. Since many known agents have been proven to be toxic, there has been increasing impetus to identify alternative tyrosinase inhibitors, especially from natural sources. In this study, we investigated 900 extracts from Greek plants for potential tyrosinase inhibitive properties. Among the five most potent extracts, the methanol extract of Morus alba wood (MAM) demonstrated a significant reduction in intracellular tyrosinase and melanin content in B16F10 melanoma cells. Bioassay-guided isolation led to the acquisition of twelve compounds: oxyresveratrol (1), kuwanon C (2), mulberroside A (3), resorcinol (4), dihydrooxyresveratol (5), trans-dihydromorin (6), 2,4,3′-trihydroxydihydrostilbene (7), kuwanon H (8), 2,4-dihydroxybenzaldehyde (9), morusin (10), moracin M (11) and kuwanon G (12). Among these, 2,4,3′-trihydroxydihydrostilbene (7) is isolated for the first time from Morus alba and constitutes a novel potent tyrosinase inhibitor (IC50 0.8 ± 0.15). We report here for the first time dihydrooxyresveratrol (5) as a potent natural tyrosinase inhibitor (IC50 0.3 ± 0.05). Computational docking analysis indicated the binding modes of six tyrosinase inhibitors with the aminoacids of the active centre of tyrosinase. Finally, we found both MAM extract and compounds 1, 6 and 7 to significantly suppress in vivo melanogenesis during zebrafish embryogenesis.

1 March 2004 in Chemistry & Biology
Verified
Journal Article
Closed access
NFNikolas Fokialakis
Nikolas Fokialakis
GLGeorge Lambrinidis
George Lambrinidis
DMDimitra J. Mitsiou
Dimitra J. Mitsiou
NANektarios Aligiannis
Nektarios Aligiannis
SMSofia Mitakou
Sofia Mitakou
MAMichael N. Alexis
Michael N. Alexis

1 September 2003 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
Panagiotis ZoumpoulakisPanagiotis Zoumpoulakis
Panagiotis Zoumpoulakis
IDI Daliani
I Daliani
MZMaria Zervou
Maria Zervou
IKI Kyrikou
I Kyrikou
ESE Siapi
E Siapi
Thomas MavromoustakosThomas Mavromoustakos
Thomas Mavromoustakos